Maria Fonseca

0 %
Maria Fonseca, PhD
Machine Learning and AI
Data Science and Analytics
  • Country:
    Portugal/ Ireland
  • City:
    Lisbon/ Dublin
  • Pronouns:
    She/ Her
PT
EN
FR
IT
ES
RU
Python
SQL
R
Java
C#, .Net
Scala
JavaScript
  • SciKit-Learn, PyTorch
  • TensorFlow, Keras, XGBoost
  • SageMaker, AzureML, VertexAI
  • AutoML, MLOps
  • Hugging Face, LangChain, LLMs
  • Power BI, Tableau, Looker, Qlik
  • Jupyter, Colab, Jetbrains IDEs
  • Docker, Kubernetes
  • AWS, Azure, GCP
  • Databricks, Snowflake, dbt
  • SQL & NoSQL Databases
  • Apache Spark, Apache Hadoop
  • Apache Airflow, Jenkins
  • Google Analytics, Tag Manager
  • SPSS, Mathematica, MatLab
  • Jira, Confluence, Git, Miro
  • ArcGIS, MaxQDA, Adobe tools

Health & Pharma

The future is Data-Driven
Contact

Overview

With a wealth of experience spanning two decades, I have established myself as a leading consultant, data analyst, data scientist, data product developer, market researcher, and commercial consultant for the pharmaceutical industry. My expertise covers a broad spectrum of medical specialties and topics, ensuring a holistic approach to product, marketing, and commercial development. Here’s an overview of some of the areas I’ve worked in with selected examples:

  1. Clinical Trials and Post-Marketing Surveillance:
    • Expertise in overseeing and interpreting phase 3 and 4 clinical trials.
    • Post-marketing safety surveillance and real-world evidence studies.
    • Benefit-risk assessments for established products.
  2. Analytics and Data Science of Medical Claims Data:
    • Advanced data mining techniques to extract insights from claims data.
    • Predictive modeling to forecast disease trends and treatment outcomes.
    • Cost analysis and healthcare utilization studies.
  3. Product Development:
    • Lifecycle management strategies.
    • Pricing and reimbursement analysis.
    • Launch readiness assessments.
  4. Marketing and Commercial Development:
    • Competitive landscape assessments.
    • Branding and positioning strategies.
    • Multichannel marketing campaign optimization.
  5. Advanced Data Science:
    • Machine learning models for predicting drug efficacy.
    • Advanced analytics for patient segmentation.
    • Data visualization tools for stakeholder communication.

Each of these areas has presented unique challenges and opportunities. My multifaceted approach, rooted in deep industry knowledge, has consistently delivered value to my clients, helping them navigate the complexities of the pharmaceutical landscape with confidence.

Some Areas

Oncology
  • Tailored drug development strategies.
  • Market research on cancer immunotherapies.
  • Patient journey analysis for various cancer types and treatments.
Cardiology
  • Analysis of market potential for novel heart failure drugs.
  • Patient adherence studies for anticoagulant therapies.
  • Marketing strategies for hypertension drugs.
Neurology
  • Patterns of prescription for neurodegenerative diseases.
  • Market sizing for migraine treatments.
  • Patient-centric approaches for epilepsy guidelines.
Endocrinology
  • Commercial strategies for diabetes care.
  • Market penetration studies for thyroid disorder drugs.
  • Data analysis on growth hormone therapy trends.
Rheumatology
  • Market analysis for rheumatoid arthritis drugs.
  • Patient segmentation studies in lupus.
  • Forecasting models for osteoporosis drug sales.
Gastroenterology
  • Commercial viability assessments for IBS drugs.
  • Patient experience studies in Crohn’s disease.
  • Marketing strategies for acid reflux medications.
Respiratory Medicine
  • Data analytics for asthma care pathways.
  • Market research on COPD patient preferences.
  • Commercial strategies for allergy medications.
Dermatology
  • Product positioning for eczema treatments.
  • Market segmentation for psoriasis therapies.
  • Data-driven insights on acne medication trends.
Infectious Diseases
  • Market forecasting for novel antibiotics.
  • Data analysis on vaccine uptake and coverage.
  • Commercial development strategies for antiviral drugs.

Selected Projects